Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2 in the history. The change appears to be a system or UI update rather than content changes to the study records.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange Detected- Added revision v3.5.0 to the Study Record Versions. - Removed revision v3.4.3 from history.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer. This is a minor system update and does not alter study records or user workflows.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page adds Revision: v3.4.2 and removes the government funding lapse notice and Revision: v3.4.1 from the history.SummaryDifference0.5%

- Check73 days agoChange DetectedA government funding status notice was added noting potential delays and that the NIH Clinical Center is open. The site revision was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

- Check80 days agoChange DetectedAdded a glossary display and color-coded highlights for record changes, and updated the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.